Wire Stories
-
491WNS Named to Forbes� 2022 List of World�s Best Employers
NEW YORK & MUMBAI, India–(BUSINESS WIRE)–$WNS #BPM–WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management (BPM) solutions, today...
-
476CTBC Bank USA CEO Noor Menai to Present at FT Global Banking Summit
Top banker to discuss Asia-Pacific�s digitalization amidst global economic challenges LOS ANGELES & LONDON–(BUSINESS WIRE)–#BankCEOs—CTBC Bank USA announced today that its President...
-
460WNS Named to Forbes� 2022 List of World�s Best Employers
NEW YORK & MUMBAI, India–(BUSINESS WIRE)–$WNS #BPM–WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management (BPM) solutions, today...
-
460Wipro Launches AWS Skills Guild Program: Step Up
AWS Skills Guild will transform the way Wipro employees engage with clients, helping drive optimal business outcomes from comprehensive AWS Cloud training...
-
407Anteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR�
U.S. Clinical Trial Commencement Anticipated in 1Q2023 BRISBANE, Australia & EAGAN, Minn.–(BUSINESS WIRE)–Anteris Technologies Ltd (ASX: AVR), a structural heart company developing...
-
464ICPO Foundation and PreMIT Enter Strategic Partnership to Develop a Network of Precision Oncology and Theranostic Centers
First-of-its-kind global network will enable improved patient access to advanced precision cancer care, provide leading edge infrastructure using the most-advanced imaging technology,...
-
451Momentus Signs Contract with Australian Research Centre to Place Satellite in Orbit
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers transportation and other in-space...
-
390Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
� Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC � � Exscientia�s A2A biomarker signature for patient...
-
471Momentus Signs Contract with Australian Research Centre to Place Satellite in Orbit
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers transportation and other in-space...
-
518Momentus Signs Contract with Australian Research Centre to Place Satellite in Orbit
SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers transportation and other in-space...
